Virginia Fitzpatrick

3.2k total citations · 1 hit paper
9 papers, 2.4k citations indexed

About

Virginia Fitzpatrick is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Virginia Fitzpatrick has authored 9 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pharmacology. Recurrent topics in Virginia Fitzpatrick's work include Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Virginia Fitzpatrick is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Virginia Fitzpatrick collaborates with scholars based in United States, Australia and Canada. Virginia Fitzpatrick's co-authors include Lloyd D. Fisher, John J. Albers, Greg Brown, Xue-Qiao Zhao, Brad Bisson, Harold T. Dodge, Robert H. Knopp, G. Russell Warnick, Howard C. Herrmann and W. Douglas Weaver and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Clinical Chemistry.

In The Last Decade

Virginia Fitzpatrick

9 papers receiving 2.3k citations

Hit Papers

Regression of Coronary Artery Disease as a Result of Inte... 1990 2026 2002 2014 1990 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
    1990 1.6k citations Greg Brown, John J. Albers et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Fitzpatrick United States 9 1.5k 883 794 288 256 9 2.4k
Athanasios A. Papageorgiou Greece 26 1.5k 1.0× 1.1k 1.2× 814 1.0× 113 0.4× 248 1.0× 46 2.7k
Genshi Egusa Japan 27 973 0.7× 1.0k 1.2× 862 1.1× 156 0.5× 209 0.8× 75 2.7k
Witold Rużyłło Poland 20 1.3k 0.9× 506 0.6× 1.3k 1.7× 533 1.9× 159 0.6× 104 2.5k
Kazuhiko Hirobe Russia 17 677 0.5× 544 0.6× 516 0.6× 109 0.4× 128 0.5× 42 1.6k
William Malbecq United States 18 830 0.6× 337 0.4× 1.5k 1.9× 325 1.1× 202 0.8× 30 2.7k
John H. Contois United States 28 1.6k 1.1× 1.6k 1.8× 686 0.9× 142 0.5× 520 2.0× 49 3.5k
Ramón Corbalán Chile 26 647 0.4× 428 0.5× 1.7k 2.2× 273 0.9× 85 0.3× 114 2.6k
Lοukianos S. Rallidis Greece 29 931 0.6× 454 0.5× 1.5k 1.8× 262 0.9× 194 0.8× 172 3.3k
Ulrich Julius Germany 28 1.5k 1.0× 1.5k 1.7× 735 0.9× 94 0.3× 257 1.0× 173 3.6k
Michael Feher United Kingdom 25 707 0.5× 1.1k 1.2× 410 0.5× 208 0.7× 89 0.3× 137 2.5k

Countries citing papers authored by Virginia Fitzpatrick

Since Specialization
Citations

This map shows the geographic impact of Virginia Fitzpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Fitzpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Fitzpatrick more than expected).

Fields of papers citing papers by Virginia Fitzpatrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Fitzpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Fitzpatrick. The network helps show where Virginia Fitzpatrick may publish in the future.

Co-authorship network of co-authors of Virginia Fitzpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Fitzpatrick. A scholar is included among the top collaborators of Virginia Fitzpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Fitzpatrick. Virginia Fitzpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Boni, Joseph, Cathie Leister, Virginia Fitzpatrick, et al.. (2005). Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomic responses in patients with advanced renal cancer. Clinical Pharmacology & Therapeutics. 77(1). 76–89. 68 indexed citations
2.
Kleiman, Neal S., John A. Ambrose, Marc Cohen, et al.. (1996). Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. Journal of the American College of Cardiology. 27(3). 536–542. 171 indexed citations
3.
McCann, Barbara S., Marit L. Bovbjerg, Deborah J. Brief, et al.. (1995). Relationship of self-effecacy to cholesterol lowering and dietary change in hyperlipidemia. Annals of Behavioral Medicine. 17(3). 221–226. 34 indexed citations
4.
Dunlay, Mary C., et al.. (1995). Losartan potassium as initial therapy in patients with severe hypertension.. PubMed. 9(11). 861–7. 18 indexed citations
5.
Smet, M. De, et al.. (1995). Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.. British Journal of Clinical Pharmacology. 40(6). 571–575. 17 indexed citations
6.
Walden, C E, Barbara S. McCann, Barbara M. Retzlaff, et al.. (1991). Alternative fat-restricted diets for hypercholesterolemia and combined hyperlipidemia: feasibility, design, subject recruitment, and baseline characteristics of the dietary alternatives study.. Journal of the American College of Nutrition. 10(5). 429–442. 20 indexed citations
7.
Brown, Greg, John J. Albers, Lloyd D. Fisher, et al.. (1990). Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B. New England Journal of Medicine. 323(19). 1289–1298. 1643 indexed citations breakdown →
8.
9.
Fitzpatrick, Virginia, et al.. (1982). The Effect of Familiar Size at Familiar Distances. Perception. 11(1). 85–91. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athanasios A. Papageorgiou Breakdown of academic impact, for papers by Genshi Egusa Breakdown of academic impact, for papers by Witold Rużyłło Breakdown of academic impact, for papers by Kazuhiko Hirobe Breakdown of academic impact, for papers by William Malbecq Breakdown of academic impact, for papers by John H. Contois Breakdown of academic impact, for papers by Ramón Corbalán Breakdown of academic impact, for papers by Lοukianos S. Rallidis Breakdown of academic impact, for papers by Ulrich Julius Breakdown of academic impact, for papers by Michael Feher
Rankless by CCL
2026